(PharmaNewsWire.Com, May 22, 2019 ) Technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases are the major factors driving the growth of the market.
Growth of the market is primarily driven by the technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and pharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.
The Single-cell Analysis Market, by cell type, is segmented into human, animal, and microbial cells. the human cells segment is expected to account for the largest share of the market. The growing application areas of human stem cells and the rising incidence of diseases such as cancer are the major factors driving the growth of this segment.
The objectives of this study are as follows:
- To define, describe, and forecast the market on the basis of products, cell type, technique, application, end user, and region.
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
Browse and in-depth TOC on “Single-cell Analysis Market”.
- North America - Europe - Asia - Rest of the World (RoW)
The Single-cell Analysis Market is highly fragmented in nature with several big as well as emerging players. Prominent players in this market include Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), and Agilent Technologies (U.S.).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
